J Grøndahl-Hansen
- Cancer Research top 0.2%
- Hematology top 0.2%
- Oncology top 1%
- Molecular Biology top 5%
- Immunology and Allergy top 0.2%
- Co-authors
- Keld DanøLars SkriverLene NielsenPeter Lommer KristensenP.A. AndreasenElisabeth RalfkiærPeter KristensenNils Brünner
- Topics
- Protease and Inhibitor Mechanisms (32 papers)Peptidase Inhibition and Analysis (17 papers)Blood Coagulation and Thrombosis Mechanisms (17 papers)
- Partner nations
- DenmarkNetherlandsNorway
In The Last Decade
J Grøndahl-Hansen
40 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 4.2k
- Hematology 2.2k
- Oncology 1.7k
- Molecular Biology 1.5k
- Immunology and Allergy 1.4k
Countries citing papers authored by J Grøndahl-Hansen
This map shows the geographic impact of J Grøndahl-Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Grøndahl-Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Grøndahl-Hansen more than expected).
Fields of papers citing papers by J Grøndahl-Hansen
This network shows the impact of papers produced by J Grøndahl-Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Grøndahl-Hansen. The network helps show where J Grøndahl-Hansen may publish in the future.
Co-authorship network of co-authors of J Grøndahl-Hansen
This figure shows the co-authorship network connecting the top 25 collaborators of J Grøndahl-Hansen. A scholar is included among the top collaborators of J Grøndahl-Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Grøndahl-Hansen. J Grøndahl-Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 13 | |
| 3 | 67 | |
| 4 | 11 | |
| 5 | 13 | |
| 6 | 46 | |
| 7 | 5 | |
| 8 | 57 | |
| 9 | 86 | |
| 10 | 27 | |
| 11 | High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. | 353 |
| 12 | Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. | 162 |
| 13 | 8 | |
| 14 | 206 | |
| 15 | 8 | |
| 16 | 208 | |
| 17 | Plasminogen Activators, Tissue Degradation, and Cancerbreakdown → | 2301 |
| 18 | 56 | |
| 19 | 48 | |
| 20 | 71 |
About J Grøndahl-Hansen
J Grøndahl-Hansen is a scholar working on Cancer Research, Hematology and Immunology and Allergy, having authored 40 papers that have together received 5.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (32 papers), Peptidase Inhibition and Analysis (17 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). The work is most often cited by research in Cancer Research (4.2k citations), Immunology and Allergy (1.4k citations) and Hematology (2.2k citations). J Grøndahl-Hansen has collaborated with scholars based in Denmark, Netherlands and Norway. Frequent co-authors include Keld Danø, Lars Skriver, Lene Nielsen, Peter Lommer Kristensen, P.A. Andreasen, Elisabeth Ralfkiær, Peter Kristensen, Nils Brünner, Leif R. Lund and Ebbe Rønne. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.